A minus 3-fold (=minus 70%) ibandronate-induced downregulation of MIR21 in the U-2 OS osteosarcoma cells might be associated with the known drug-induced RAS-inactivation in this cell line [47]. Here, MIR21 is linked to osteosarcoma.